Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;13(2):185-6.
doi: 10.1038/aja.2010.161. Epub 2010 Dec 13.

Cabazitaxel: a new drug for metastatic prostate cancer

Affiliations

Cabazitaxel: a new drug for metastatic prostate cancer

Marijo Bilusic et al. Asian J Androl. 2011 Mar.
No abstract available

PubMed Disclaimer

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49. - PubMed
    1. Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jr, Jones JA, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:1513–20. - PubMed
    1. Sartor A, Oudard S, Ozguroglu M, Hansen S, Machiels J, et al. Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: final results of a multinational phase III trial (TROPIC) [abstract]. Proceedings of the ASCO Genitourinary Cancers Symposium; 5–7 March San Francisco, CA, USAASCO: Alexandria, VA, USA, 2010, No. 9.2010
    1. Engels FK, Sparreboom A, Mathot RA, Verweij J. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br J Cancer. 2005;93:173–7. - PMC - PubMed
    1. Brooks TA, Minderman H, O'Loughlin KL, Pera P, Ojima I, et al. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Mol Cancer Ther. 2003;2:1195–205. - PubMed